ArticleClinical drug investigation2026

A Randomized Four-Period Cross-Over Phase I Study to Assess Bioavailability, Bioequivalence, and Tolerability of IHL-42X Compared with the Reference Drugs in Healthy Volunteers.

George Williams Mbogo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.